May 14th, 2018
Beam Therapeutics launched to develop Harvard base editing technology toward precision genetic medicines
Harvard innovations enable the correction of single-base mutations in DNA with unprecedented precision and efficiency
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
May 14th, 2018
Harvard innovations enable the correction of single-base mutations in DNA with unprecedented precision and efficiency
March 20th, 2018
A startup, Pairwise Plants, aims to create new tools to efficiently address global food challenges
October 25th, 2017
Technique has potential to help reverse the most common type of disease-associated mutations
April 21st, 2016
Nature publication describes key advances in the laboratory of Prof. David Liu
August 10th, 2015
Editas was formed in November 2013 to develop genomic editing technologies licensed from medical research labs at Harvard University, Massachusetts General Hospital, and the Broad Institute of MIT and Harvard.